(Q38838337)

English

Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.

scientific article published on 31 August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

Tomohito Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Michihiko Nakamura

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yoshihiro J Ono

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Masanori Kanemura

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Masami Hayashi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yoshito Terai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Masahide Ohmichi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

31 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

139

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

345-354

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Treatment goals in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Ovarian carcinoma diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Drug development of MET inhibitors: targeting oncogene addiction and expedience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Pathway specificity for Met signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Overexpression of the Met/HGF receptor in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

A randomized study of screening for ovarian cancer: a multicenter study in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

The Met tyrosine kinase receptor in development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.08.010

7 January 2021

Identifiers

10.1016/J.YGYNO.2015.08.010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26335595%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38838337&oldid=1505442959"